Given today's short hospital stays after transcatheter aortic valve replacement (TAVR), there may be a role for selective long-term monitoring to flag delayed conduction abnormalities, studies showed.

Delayed cases of total atrioventricular block (AVB) or complete heart block can occur more than 2 days after TAVI, two new studies affirm, highlighting the utility of extended ECG monitoring after ...

Unlike any single-lead or 6-lead consumer device, HeartBeam's patented cable-free technology captures the heart's electrical signals in three non-coplanar dimensions and synthesizes them into a ...

Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...

A new consensus document released this week, complete with treatment algorithms, hopes to reduce the number of potentially deadly conduction disturbances following TAVR, including new-onset left ...

Researchers at the Yale Cardiovascular Data Science (CarDS) Lab have developed an artificial intelligence (AI)-based model for clinical diagnosis that can use electrocardiogram (ECG) images, ...

This is a narrow complex tachycardia with a rate of 124 beats/min. The QRS morphology and axis are normal. The QTc is prolonged, at 529 ms (normal, 390-450 ms for men). The underlying P waves appear ...

During the pause, there is a P wave (see arrows in Figure 2), ruling out SA block or sinus arrest right away. The P wave does not occur at the regular PP interval, but it definitely occurs prematurely ...

Please provide your email address to receive an email when new articles are posted on . We see this all the time: A routine ECG shows a left anterior fascicular block (also known as LAFB or left ...

Implementing large-scale ECG screening before high school sport participation could detect heart abnormalities that carry the risk of sudden cardiac death if left unchecked, a researcher reported.

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...